Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cole West Closes on 38 Homesites in Northern Utah for New Community
-
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
-
Royale® Launches “There for All”: A New Platform Celebrating the Moments That Matter Most to Canadians
-
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
-
COSCIENS Biopharma Inc. Provides Update on its Plan to Suspend U.S. Public Company Reporting Obligations
-
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
-
VVC Grants Options
-
ASML reports transactions under its current share buyback program
-
Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth
-
Max Immunity Clinic Opens in Markham, Offering Regenerative and Recovery-Based Therapies
-
American Hotel Income Properties REIT LP Announces Settlement with Its Hotel Management Company
-
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
-
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
-
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
-
Group Coaching Weekly Launches Live Program Focused on Structured Thinking and Real-Time Growth
-
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
-
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdo
-
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
-
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
-
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
-
Airsys Introduces Next-Generation LiquidRack™ Technology to Provide a Simpler Liquid Cooling Architecture for Retrofit, Edge, and Mid-Density AI Infrastructure
-
Astec Names Chad Hartley Group President – Infrastructure Solutions
-
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
-
Abacus Global Management to Participate in the 2026 Milken Institute Global Conference
-
Global Uranium Completes Phase 1 Earn-In at Astro Project and Secures Initial 20% Interest
-
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
-
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
-
Aptean introduces AI platform and AI agents for Business Central On-Premises Customers
-
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor
-
Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview
-
Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income
-
Prepayments, Realkredit Danmark A/S
-
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
-
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
-
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
-
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
-
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
-
Transactions in connection with share buyback programme
-
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
-
Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System
-
Erdene Provides Q1 2026 Bayan Khundii Gold Mine Update
-
Winshear Grants 2,000,000 Stock Options
-
AlphaTON Capital Rebrands as Alpha Compute Corp. to Reflect Its Growing AI Compute Business
-
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting
-
First Trust Launches an ETF for a New Era in the Industry
-
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
-
Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%
-
Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors
-
Xtract One Selected by Health PEI for Phased Rollout of Tech-Driven Security Systems Across Prince Edward Island
-
Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
